Bio-Rad - Preparing for a Stress-free QC Audit

INTEGRA Biosciences submits science-based emissions reduction targets to join the SBTi

INTEGRA Biosciences is proud to announce that it has submitted company-wide emissions reduction targets through the Science Based Targets initiative (SBTi), with the aim of limiting global warming to 1.5 °C and achieving net zero by 2050 at the latest.

The SBTi partnership independently assesses and approves companies’ targets in line with strict criteria, helping to define and support best practices for ambitious climate action in the private sector. To join this initiative, INTEGRA has published a report summarizing the carbon footprint of its production sites and sales offices, and publicly committed to the following emissions reduction targets:

  • A 42 % reduction in absolute greenhouse gas emissions by 2031, and a 90 % reduction by 2050.
  • To increase the annual percentage of renewable energy sources from 48 % in 2021 to 100 % by 2030.
  • A 51.6 % reduction in greenhouse gas emissions along the value chain per revenue by 2031, and a 97 % reduction by 2050.
US headquarters equipped with rooftop solar panels scaled e1680866254875

INTEGRA has outlined a comprehensive action plan to achieve this, and proactive developments are already in place to align with a net zero future while ensuring positive impacts for the company’s employees and the communities it serves.

Ursula Leuthold, Sustainability Coordinator at INTEGRA Biosciences, commented: “INTEGRA is proud to be setting 1.5 °C-aligned science-based targets with SBTi, joining the global campaign to rapidly scale back greenhouse gas emissions. We believe that, by setting credible and independently validated emission targets, we can accelerate deep and urgent decarbonization within our business and beyond.”

For more information about INTEGRA Biosciences, visit

About INTEGRA Biosciences

INTEGRA Biosciences ( is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.